Targeting SOS1 overcomes imatinib resistance with BCR-ABL independence through uptake transporter SLC22A4 in CML: Molecular Therapy - Oncolytics
Molecular mechanisms of resistance of leukemia to imatinib mesylate - ScienceDirect
Adaptive phenotypic modulations lead to therapy resistance in chronic myeloid leukemia cells | PLOS ONE
Mechanisms of Autoinhibition and STI-571/Imatinib Resistance Revealed by Mutagenesis of BCR-ABL: Cell
Frontiers | Advances in the research of the mechanism of secondary resistance to imatinib in gastrointestinal stromal tumors
![PDF] Mechanisms of Resistance to Imatinib and Second-Generation Tyrosine Inhibitors in Chronic Myeloid Leukemia | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/0a9b23d5cd08b70bab6df94e2948ce56a8452958/6-Figure1-1.png "PDF] Mechanisms of Resistance to Imatinib and Second-Generation Tyrosine Inhibitors in Chronic Myeloid Leukemia | Semantic Scholar")
PDF] Mechanisms of Resistance to Imatinib and Second-Generation Tyrosine Inhibitors in Chronic Myeloid Leukemia | Semantic Scholar
Bcr-Abl and Imatinib (STI571 or Gleevec) - Proteopedia, life in 3D
use of a monoclonal antibody to bypass imatinib resistance in... | Download Scientific Diagram
Imatinib Resistance and Progression of CML to Blast Crisis: Somatic Hypermutation AIDing the Way - ScienceDirect
Detection of mutations in CML patients resistant to tyrosine kinase inhibitor: imatinib mesylate therapy | SpringerLink
Managing resistance in chronic myeloid leukemia. | Semantic Scholar
Deubiquitylation of Rab35 by USP32 promotes the transmission of imatinib resistance by enhancing exosome secretion in gastrointestinal stromal tumours | Oncogene
PPT - POSSIBLE MECHANISMS OF IMATINIB RESISTANCE PowerPoint Presentation - ID:2706746
Overcoming imatinib resistance in chronic myelogenous leukemia cells using non-cytotoxic cell death modulators - ScienceDirect
Frontiers | BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia
Imatinib resistance mechanisms. Imatinib resistance can be attributed... | Download Scientific Diagram
Mechanisms of imatinib resistance in CML. Clinical imatinib resistance... | Download Scientific Diagram
IJMS | Free Full-Text | Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update
Mechanisms of Resistance to Targeted Therapies in Chronic Myeloid Leukemia | SpringerLink
Mechanisms of resistance towards imatinib. (a) Imatinib is available... | Download Scientific Diagram
Imatinib resistance in chronic myeloid leukaemia caused by Bcr-Abl kinase domain and non-Bcr-Abl mutations: a comparison and review. | Australian Medical Student Journal
Imatinib Pathway, Pharmacokinetics/Pharmacodynamics
Frontiers | Combination Therapies in Chronic Myeloid Leukemia for Potential Treatment-Free Remission: Focus on Leukemia Stem Cells and Immune Modulation
5MJCB4-TKI
Semi‑random mutagenesis profile of BCR‑ABL during imatinib resistance acquirement in K562 cells
Imatinib - Wikipedia
